These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36646351)

  • 1. Study on endogenous inhibitors against PD-L1: cAMP as a potential candidate.
    Huang Q; Zang X; Zhang Z; Yu H; Ding B; Li Z; Cheng S; Zhang X; Ali MRK; Qiu X; Lv Z
    Int J Biol Macromol; 2023 Mar; 230():123266. PubMed ID: 36646351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, synthesis, pharmacological evaluation, and computational study of benzo[d] isothiazol-based small molecule inhibitors targeting PD-1/PD-l1 interaction.
    Wang H; Shen L; Chen L; Gao Y; Ma L; Lian W; Zhang Z; Liu H; Yang H; Wang J; Zhao D; Cheng M
    Eur J Med Chem; 2024 Sep; 275():116622. PubMed ID: 38959727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of benzo[d]isothiazole derivatives as novel scaffold inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction through "ring fusion" strategy.
    Gao Y; Wang H; Shen L; Xu H; Deng M; Cheng M; Wang J
    Bioorg Chem; 2022 Jun; 123():105769. PubMed ID: 35405572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis, and biological evaluation of 1-methyl-1H-pyrazolo[4,3-b]pyridine derivatives as novel small-molecule inhibitors targeting the PD-1/PD-L1 interaction.
    Dai X; Wang K; Chen H; Huang X; Feng Z
    Bioorg Chem; 2021 Sep; 114():105034. PubMed ID: 34116264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the Triggering of PD-L1 Dimerization a Potential Mechanism for Food-Derived Small Molecules in Cancer Immunotherapy? A Study by Molecular Dynamics.
    Wu X; Wang N; Liang J; Wang B; Jin Y; Liu B; Yang Y
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of quinazoline derivatives as novel small-molecule inhibitors targeting the programmed cell death-1/programmed cell death-ligand 1 (PD-1/PD-L1) interaction.
    Wang Y; Kun Huang ; Gao Y; Yuan D; Ling L; Liu J; Wu S; Chen R; Li H; Xiong Y; Liu H; Ma J
    Eur J Med Chem; 2022 Feb; 229():113998. PubMed ID: 34839997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and pharmacological evaluation of novel resorcinol biphenyl ether analogs as small molecule inhibitors of PD-1/PD-L1 with benign toxicity profiles for cancer treatment.
    Cao H; Cheng B; Liu T; Chen J
    Biochem Pharmacol; 2021 Jun; 188():114522. PubMed ID: 33741334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, evaluation, and SAR of 4-phenylindoline derivatives, a novel class of small-molecule inhibitors of the programmed cell death-1/ programmed cell death-ligand 1 (PD-1/PD-L1) interaction.
    Yang Y; Wang K; Chen H; Feng Z
    Eur J Med Chem; 2021 Feb; 211():113001. PubMed ID: 33272783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kaempferol and Its Glycoside, Kaempferol 7-O-Rhamnoside, Inhibit PD-1/PD-L1 Interaction In Vitro.
    Kim JH; Kim YS; Choi JG; Li W; Lee EJ; Park JW; Song J; Chung HS
    Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32375257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization.
    Guo Y; Jin Y; Wang B; Liu B
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of the programmed cell death-1/programmed cell death-ligand 1 interaction inhibitors bearing an indoline scaffold.
    Qin M; Cao Q; Wu X; Liu C; Zheng S; Xie H; Tian Y; Xie J; Zhao Y; Hou Y; Zhang X; Xu B; Zhang H; Wang X
    Eur J Med Chem; 2020 Jan; 186():111856. PubMed ID: 31734021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of the PD-1/PD-L1 binding inhibitor BMS-202 in the humanized MHC-double knockout NOG mouse.
    Ashizawa T; Iizuka A; Tanaka E; Kondou R; Miyata H; Maeda C; Sugino T; Yamaguchi K; Ando T; Ishikawa Y; Ito M; Akiyama Y
    Biomed Res; 2019; 40(6):243-250. PubMed ID: 31839668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of low-molecular weight anti-PD-L1 peptides for cancer immunotherapy.
    Liu H; Zhao Z; Zhang L; Li Y; Jain A; Barve A; Jin W; Liu Y; Fetse J; Cheng K
    J Immunother Cancer; 2019 Oct; 7(1):270. PubMed ID: 31640814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Mechanism of Food-Derived Polyphenols on PD-L1 Dimerization: A Molecular Dynamics Simulation Study.
    Guo Y; Liang J; Liu B; Jin Y
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of Novel Small-Molecule Inhibitors of PD-1/PD-L1 Interaction via Structural Simplification Strategy.
    Zhang H; Xia Y; Yu C; Du H; Liu J; Li H; Huang S; Zhu Q; Xu Y; Zou Y
    Molecules; 2021 Jun; 26(11):. PubMed ID: 34199417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of phenyl-linked symmetric small molecules as inhibitors of the programmed cell death-1/programmed cell death-ligand 1 interaction.
    Wu Y; Zhang Y; Guo Y; Pan Z; Zhong S; Jin X; Zhuang W; Chen S; Gao J; Huang W; Dong X; Che J
    Eur J Med Chem; 2021 Nov; 223():113637. PubMed ID: 34147746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rational design and development of a peptide inhibitor for the PD-1/PD-L1 interaction.
    Boohaker RJ; Sambandam V; Segura I; Miller J; Suto M; Xu B
    Cancer Lett; 2018 Oct; 434():11-21. PubMed ID: 29920293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro characterization of a small molecule PD-1 inhibitor that targets the PD-l/PD-L1 interaction.
    Lu CH; Chung WM; Tsai CH; Cheng JC; Hsu KC; Tzeng HE
    Sci Rep; 2022 Jan; 12(1):303. PubMed ID: 34996924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Biphenyl Pyridines as Potent Small-Molecule Inhibitors Targeting the Programmed Cell Death-1/Programmed Cell Death-Ligand 1 Interaction.
    Wang T; Cai S; Wang M; Zhang W; Zhang K; Chen D; Li Z; Jiang S
    J Med Chem; 2021 Jun; 64(11):7390-7403. PubMed ID: 34056906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational design of PD-L1 small molecule inhibitors for cancer therapy.
    Chandrasekaran J; Elumalai S; Murugesan V; Kunjiappan S; Pavadai P; Theivendren P
    Mol Divers; 2023 Aug; 27(4):1633-1644. PubMed ID: 36006501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.